RecruitingPhase 4NCT06581328
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Sponsor: Takeda
El Paso, TX · Georgetown, TX · Houston, TX · +98 more sites
Clinical trials in Webster, TX
23 recruiting studies have a site in or near Webster, TX, Texas.
Top conditions here
- Ulcerative Colitis (6)
- Lung Cancer (5)
- Psoriasis (4)
- Crohn's Disease (4)
- Breast Cancer (3)
- Obesity (1)
- Parkinson's Disease (1)
- Lupus (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 23 of 23 studies
RecruitingPhase 3NCT06952504
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Sponsor: Merck Sharp & Dohme LLC
Fort Worth, TX · Houston, TX · San Antonio, TX · +50 more sites
RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Arlington, TX · Cypress, TX · Dallas, TX · +119 more sites
RecruitingPhase 3NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Sponsor: Pfizer
Abilene, TX · Allen, TX · Amarillo, TX · +238 more sites
RecruitingPhase 3NCT07174336
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Sponsor: Eli Lilly and Company
Abilene, TX · Baytown, TX · Dallas, TX · +126 more sites
RecruitingPhase 2NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Cedar Park, TX · Dallas, TX · Fort Worth, TX · +37 more sites
RecruitingPhase 3NCT07222566
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor: Pfizer
Abilene, TX · Allen, TX · Amarillo, TX · +223 more sites
RecruitingPhase 3NCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Sponsor: Eli Lilly and Company
Austin, TX · Fort Bliss, TX · Houston, TX · +84 more sites
RecruitingPhase 2NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Sponsor: Spyre Therapeutics, Inc.
Cedar Park, TX · Garland, TX · San Antonio, TX · +23 more sites
RecruitingPhase 3NCT06961214
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Sponsor: GlaxoSmithKline
Austin, TX · Dallas, TX · El Paso, TX · +54 more sites
RecruitingPhase 1 / Phase 2NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Sponsor: Xencor, Inc.
Cedar Park, TX · Denton, TX · Garland, TX · +27 more sites
RecruitingPhase 3NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Dallas, TX · Fort Worth, TX · Garland, TX · +58 more sites
RecruitingPhase 2NCT07449702
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Sponsor: Oruka Therapeutics, Inc.
Frisco, TX · Houston, TX · Webster, TX · +19 more sites
RecruitingPhase 3NCT07362017
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Sponsor: Vanda Pharmaceuticals
San Antonio, TX · Webster, TX · +8 more sites
RecruitingPhase 4NCT06095128
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Sponsor: Takeda
Dallas, TX · Houston, TX · Mansfield, TX · +34 more sites
RecruitingPhase 3NCT06767514
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Sponsor: Summit Therapeutics
Abilene, TX · Austin, TX · Dallas, TX · +94 more sites
RecruitingPhase 4NCT06045754
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Sponsor: Takeda
Cedar Park, TX · Dallas, TX · Houston, TX · +38 more sites
RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor: Eli Lilly and Company
Bellaire, TX · Dallas, TX · Houston, TX · +36 more sites
RecruitingPhase 3NCT06072612
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Sponsor: BriaCell Therapeutics Corporation
Dallas, TX · Edinburg, TX · +76 more sites
RecruitingPhase 1NCT07041099
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Sponsor: Cullinan Therapeutics Inc.
Plano, TX · Webster, TX · +4 more sites
RecruitingPhase 1NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Houston, TX · +103 more sites
RecruitingPhase 1NCT06613360
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Sponsor: Cullinan Therapeutics Inc.
Plano, TX · Webster, TX · +8 more sites
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Dallas, TX · Garland, TX · Georgetown, TX · +43 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.